Yellow Fever Vaccine Market Responds to Changing Challenges

  • Yellow fever virus is closely related to West Nile Virus.
  • Increasing prevalence of yellow fever, unhygienic lifestyle and growing awareness among populations are market drivers to find a treatment to cure yellow fever.
  • There is no specific treatment for yellow fever, but symptoms can be treated as the body fights off the virus.

Yellow fever is viral disease is spread by mosquitoes. Yellow fever is a flavivirus disease occurring in the tropical areas of sub Saharan Africa, South America, parts of Central America and parts of Caribbean. Yellow fever virus is closely related to West Nile Virus.

The mosquitoes which spread yellow fever are usually active and bite during daylight hours.  It is not a contagious disease and cannot spread from one infected person to other. Rise of yellow fever internationally is due to decreased immunity to infection among local populations, climate change and high density urbanization. According to CDC, 15% of the people who develop yellow fever develop a serious illness that is sometimes fatal.

Efforts by the World Health Organization and UNICEF propel growth of the Yellow Fever Vaccine Market.

Travelers to certain parts of African and Latin American countries are at higher risk for yellow fever. Symptoms of yellow fever include chills, onset of fever, back pain, severe headache, fatigue and weakness and nausea and vomiting.

There is no specific treatment for yellow fever, but symptoms can be treated as the body fights off the virus. According to WHO, approximately 200,000 cases of yellow fever occur each year. The only available treatment for yellow fever is a vaccine, which provides lifelong protection. Yellow fever vaccinations are carried out to prevent the international spread of the disease and protect individual travelers who may be exposed to yellow fever infection.

For detailed insights, request a Sample here

Increasing prevalence of yellow fever, unhygienic lifestyle and growing awareness among populations are market drivers to find a treatment to cure yellow fever. Improving healthcare infrastructure in several emerging countries such as Brazil, and an increase in the number of travelers to the endemic countries also drive the Yellow Fever Vaccine Market.

Efforts by the World Health Organization and UNICEF propel growth of the Yellow Fever Vaccine Market. Long term agreements with manufacturers to provide vaccine and routine programs, emergency and preventive campaigns also drive the market. However, an insufficient supply of vaccines to meet increasing demands hampers growth of the Yellow Fever Vaccine Market.

Segmentation

The global Yellow Fever Vaccine Market is segmented on basis of end user and geographic region:

Segmentation by End Users:  Hospitals, , Diagnostic Centers, Point of Care Centers and Others.  Segmentation by Geography:  North America, Latin America, Europe, Asia-Pacific Excluding China, China, and Middle East & Africa.

To receive extensive list of important regions, ask for TOC here

There is no specific treatment for yellow fever, but symptoms can be treated as the body fights off the virus.

On the basis of end user, hospitals have the largest share, owing to increase in number of vaccinations for yellow fever and a rise in awareness about the vaccination among people traveling to endemic regions such as Africa and Latin America. Diagnostic centers are anticipated to show fast growth during the forecast period.

However, on the basis of geography, global Yellow Fever Vaccine Market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. Middle East & Africa captured the largest share in global Yellow Fever Vaccine Market owing to highest incidence of yellow fever in this region.

Latin America is anticipated to share the second largest revenue share owing to increasing medical tourism in Brazil and Mexico, suitable expenditure on medical and emergency care by international public and healthcare groups, especially from United Nations and Western Europe, as well as penetration of advanced therapeutic lines of treatment in the semi urban and rural counties in Latin America. Adoption of commercialized vaccines in the end user segment manufactured by overseas manufacturers is going to spur revenue growth during the forecast period in Latin America.

Some of the key players present in global Yellow Fever Vaccine Market are: Sanofi Pasteur SA, Bio-Manguinhos, Institut Pasteur de Dakar, FSUE Chumakov, iBio Inc.

For in-depth competitive analysis, Check Pre-Book here

The report covers exhaustive analysis on: Yellow Fever Vaccine Market Segments, Yellow Fever Vaccine Market Dynamics, Historical Actual Market Size, 2012 – 2016, Yellow Fever Vaccine Market , ize & Forecast 2016 to 2024, Yellow Fever Vaccine Market Current Trends/Issues/Challenges, Competition & Companies involved, and Yellow Fever Vaccine Market Drivers and Restraints.

Only $1/click

Submit Your Ad Here

Swapna Supekar

Swapna work as a Sr. Digital Marketing Consultant with Persistence Market Research. 
https://www.persistencemarketresearch.com

Leave a Reply